07:00 , Jun 15, 2015 |  BC Week In Review  |  Company News

University of South Florida, Cellular Biomedicine deal

Cellular Biomedicine received an exclusive, worldwide license to cancer vaccine CD40LGVAX from Blackbird Bio Finance, which held rights to the vaccine discovered by University of South Florida College of Medicine. CD40LGVAX consists of irradiated...
01:51 , Jun 10, 2015 |  BC Extra  |  Company News

CBMG gets NSCLC vaccine, plans combo trial with Opdivo

Cellular Biomedicine Group Inc. (NASDAQ:CBMG) said it acquired cancer vaccine CD40LGVAX from Blackbird Bio Finance, which held rights to the vaccine discovered by University of South Florida College of Medicine professor Scott Antonia. CD40LGVAX consists...